WeLeader Biomedical Co., Ltd. (TPEX: 7713)

Market Cap	3.28B
Revenue	n/a
Net Income	n/a
Shares Out	41.58M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	2.30 (2.91%)
Ex-Dividend Date	n/a

Volume	5,000
Open	80.00
Previous Close	80.00
Day's Range	79.00 - 80.00
52-Week Range	64.70 - 86.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About WeLeader Biomedical

WeLeader Biomedical Co., Ltd. operates as an agent and distributor of in vitro diagnostic products. It offers a range of medical testing systems, such as serum biochemistry integration platform, clinical care, and medical information integration system. The company also provides blood gas electrolyte analyzers, urine analyzers, integrated fully automatic biochemical analyzers, fully automatic electronic luminescence immunoassay products, fully automatic modular biochemical immune assay products, TTA automated pre-processing products, POCT centr...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 1992
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7713